JYNT - ジョイント (The Joint Corp.) ジョイント

 JYNTのチャート


 JYNTの企業情報

symbol JYNT
会社名 Joint Corp (New) (ジョイント)
分野(sector) Miscellaneous   雑工業
産業(industry) Multi-Sector Companies  
業種 ヘルスケア施設_サ―ビス   その他(Other)
概要 事業概要 The Joint Corp. develops owns operates supports and manages chiropractic clinics through direct ownership management arrangements franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has approximately 310 franchised company-owned or managed clinics in operation in over 30 states. In addition to its approximately 310 operating clinics the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient''s records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.   ジョイントは米国のカイロプラクティック診療所の運営会社。非保険、現金ベ―スのカイロプラクティック診療所を運営する。資格保持のカイロプラクタ―のみを採用したフランチャイズ形式で、質の高い、手軽な料金設定の診療所のネットワ―クを展開。カイロプラクティック治療を通じて、顧客の生活の質を改善することを目標とする。本社はアリゾナ州。   The Joint Corp. revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, the company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. With nearly 600 locations nationwide and over eight million patient visits annually, The Joint is a key leader in the chiropractic industry. Named on Franchise Times 'Top 200+ Franchises' and Entrepreneur's 'Franchise 500®' lists, The Joint Chiropractic is an innovative force, where healthcare meets retail.
本社所在地 16767 N. Perimeter Drive Suite 240 Scottsdale AZ 85260 USA
代表者氏名 Peter D. Holt ピーター・D・ホルト
代表者役職名 Chief Executive Officer Interim Principal Financial Officer Director
電話番号 +1 480-245-5960
設立年月日 40238
市場名 NASDAQ Small Cap
ipoyear 2014年
従業員数 148人
url www.thejoint.com
nasdaq_url https://www.nasdaq.com/symbol/jynt
adr_tso
EBITDA EBITDA(百万ドル) 0.83639
終値(lastsale) 8.63
時価総額(marketcap) 118455328.22
時価総額 時価総額(百万ドル) 115.02380
売上高 売上高(百万ドル) 28.13009
企業価値(EV) 企業価値(EV)(百万ドル) 111.54077
当期純利益 当期純利益(百万ドル) 2.85331
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Joint Corp revenues increased 27% to $14.7M. Net loss decreased 85% to $430K. Revenues reflect Revenues and management fees from compan increase of 29% to $6.7M Royalty fees increase of 32% to $4.7M Franchise fees increase of 21% to $797K. Lower net loss reflects Depreciation decrease of 28% to $549K (expense) Loss on disposition or impairment decrease of 40% to $251K (expense).

 JYNTのテクニカル分析


 JYNTのニュース

   The Joint Corp. (NASDAQ: JYNT) Shares Rose Recently, But Trouble Could Still Be Around The Corner.  2022/09/05 14:00:00 Stocks Register
The Joint Corp. (NASDAQ:JYNT) price closed lower on Friday, September 02, dropping -5.27% below its previous close. A look at the daily price movement shows that the last close reads $17.82, with intraday deals fluctuated between $16.655 and $18.52. The company’s 5Y monthly beta was ticking 1.34 while its P/E ratio in the trailing 12-month … The Joint Corp. (NASDAQ: JYNT) Shares Rose Recently, But Trouble Could Still Be Around The Corner. Read More »
   The Joint Corp.''s (JYNT) CEO Peter Holt on Q2 2022 Results - Earnings Call Transcript  2022/08/07 07:26:05 Seeking Alpha
The Joint Corp. (NASDAQ:NASDAQ:JYNT) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief…
   The Joint Corp. 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:JYNT)  2022/08/07 06:48:05 Seeking Alpha
The following slide deck was published by The Joint Corp.
   Joint Corp: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape (JYNT)  2022/08/05 17:06:36 Seeking Alpha
The Joint Corp. posted Q2 FY22 earnings yesterday with upsides in revenue and EPS versus consensus.
   B.Riley Upgrades The Joint Corp to Buy  2022/08/05 12:12:03 Investing.com
https://www.investing.com/news/pro/briley-upgrades-the-joint-corp-to-buy-432SI-2865239
   Joint Corp: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape (JYNT)  2022/08/05 17:06:36 Seeking Alpha
The Joint Corp. posted Q2 FY22 earnings yesterday with upsides in revenue and EPS versus consensus.
   B.Riley Upgrades The Joint Corp to Buy  2022/08/05 12:12:03 Investing.com
https://www.investing.com/news/pro/briley-upgrades-the-joint-corp-to-buy-432SI-2865239
   Maxim Group Upgrades The Joint Corp to Buy  2022/08/05 12:12:01 Investing.com
https://www.investing.com/news/pro/maxim-group-upgrades-the-joint-corp-to-buy-432SI-2865238
   Recap: Joint Q2 Earnings  2022/08/04 22:01:37 Benzinga
Joint (NASDAQ: JYNT ) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings Joint beat estimated earnings by 100.0%, reporting an EPS of $0.02 versus an … Full story available on Benzinga.com
   The Joint Corp. Reports Second Quarter 2022 Financial Results  2022/08/04 20:05:00 GlobeNewswire
- Grew Revenue 24%, System-wide Sales 21%, and System-wide Comp Sales 8% vs. Q2 2021 - - Opened 34 Clinics, Bringing Total Clinics to 769 - - Sold 24 Franchise Licenses, Bringing the Year-to-Date Total to 46 -
   Joint acquires four previously owned franchised clinics for $5.8M, strengthening the Scottsdale/Phoenix region cluster  2022/05/23 11:38:01 Seeking Alpha
Joint (JYNT) acquired four previously owned franchised clinics for $5.8M on May 19, 2022. “This opportunity arose with a multi-unit franchisee with clinics…
   Analyst Ratings for Joint  2022/05/10 18:05:34 Benzinga
Joint (NASDAQ: JYNT ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 1 2 0 Last 30D 0 0 0 1 0 1M Ago 0 0 1 1 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 These 4 analysts have an average price target of $31.25 versus the current price of Joint at $16.575, implying upside. Below is a summary of how these 4 analysts rated Joint over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and … Full story available on Benzinga.com
   The Joint Corp''s (JYNT) CEO Peter Holt on Q1 2022 Results - Earnings Call Transcript  2022/05/08 05:46:04 Seeking Alpha
The Joint Corp. (NASDAQ:NASDAQ:JYNT) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief…
   The Joint Corp. (NASDAQ: JYNT) Stock Has Dropped -19.50% Over The Month – Is There Room For Growth?  2022/05/06 20:00:00 Marketing Sentinel
The Joint Corp. (NASDAQ:JYNT)’s traded shares stood at 2.34 million during the latest session, with the company’s beta value hitting 1.28. At the last check today, the stock’s price was $15.85, to imply a decrease of -43.45% or -$12.18 in intraday trading. The JYNT share’s 52-week high remains $111.06, putting it -600.69% down since that … The Joint Corp. (NASDAQ: JYNT) Stock Has Dropped -19.50% Over The Month – Is There Room For Growth? Read More »
   ChemoCentryx, iRhythm top healthcare gainers; Joint, Endo lead losers'' pack  2022/05/06 14:05:50 Seeking Alpha
ChemoCentryx CCXI +19%. iRhythm Technologies IRTC +16%. Joint JYNT -46%. Endo International ENDP -34%.

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 ジョイント JYNT The Joint Corp.)

 twitter  (公式ツイッターやCEOツイッターなど)